RAD\u0130KAL S\u0130STEKTOM\u0130 NE ZAMAN GEREK\u0130R?<\/b><\/p>\n
Mesanenin Al\u0131nmas\u0131 Gereken Durumlar Nelerdir?<\/b><\/p>\n
Do\u00e7. Dr. Serdar Yal\u00e7\u0131n
\u00dcroloji Uzman\u0131<\/p>\n
KISA \u00d6ZET<\/b><\/p>\n
Radikal sistektomi, mesane kanserinde mesanenin ve \u00e7evresindeki ilgili dokular\u0131n cerrahi olarak \u00e7\u0131kar\u0131lmas\u0131 i\u015flemidir. Kas invaziv mesane kanseri (MIBC) i\u00e7in standart tedavilerden biridir ve baz\u0131 y\u00fcksek riskli kas invaziv olmayan mesane kanseri (NMIBC) hastalar\u0131nda da \u00f6nerilebilir. Avrupa \u00dcroloji Birli\u011fi (EAU) 2026 K\u0131lavuzlar\u0131na g\u00f6re do\u011fru hasta se\u00e7imi ve zaman\u0131nda uygulanan radikal sistektomi, uzun d\u00f6nem kanser kontrol\u00fc a\u00e7\u0131s\u0131ndan en etkili tedavi se\u00e7eneklerinden biridir.<\/p>\n
\u0130\u00c7\u0130NDEK\u0130LER<\/b><\/p>\n
Radikal sistektomi nedir?<\/p>\n
Hangi hastalarda \u00f6nerilir?<\/p>\n
Mesanenin al\u0131nmas\u0131 neden gerekli olabilir?<\/p>\n
Ameliyat neleri i\u00e7erir?<\/p>\n
Mesane al\u0131nd\u0131ktan sonra idrar nas\u0131l yap\u0131l\u0131r?<\/p>\n
Robotik cerrahi m\u00fcmk\u00fcn m\u00fcd\u00fcr?<\/p>\n
EAU 2026\u2019n\u0131n hasta i\u00e7in \u00f6nemli mesaj\u0131<\/p>\n
Do\u00e7. Dr. Serdar Yal\u00e7\u0131n ile radikal sistektomi<\/p>\n
S\u0131k Sorulan Sorular<\/p>\n
RAD\u0130KAL S\u0130STEKTOM\u0130 NED\u0130R?<\/b><\/p>\n
Radikal sistektomi, mesanenin tamamen \u00e7\u0131kar\u0131ld\u0131\u011f\u0131 ileri d\u00fczey bir \u00fcroonkolojik ameliyatt\u0131r.<\/p>\n
Erkeklerde genellikle prostat ve seminal vezik\u00fcller de \u00e7\u0131kar\u0131l\u0131r.<\/p>\n
Kad\u0131nlarda ise hastal\u0131\u011f\u0131n yay\u0131l\u0131m\u0131na g\u00f6re mesane ile birlikte \u00e7evredeki baz\u0131 organlar\u0131n \u00e7\u0131kar\u0131lmas\u0131 gerekebilir.<\/p>\n
Ameliyat s\u0131ras\u0131nda pelvik lenf nodlar\u0131n\u0131n \u00e7\u0131kar\u0131lmas\u0131 da tedavinin \u00f6nemli bir par\u00e7as\u0131d\u0131r.<\/p>\n
HANG\u0130 HASTALARDA \u00d6NER\u0130L\u0130R?<\/b><\/p>\n
EAU 2026 K\u0131lavuzlar\u0131na g\u00f6re radikal sistektomi a\u015fa\u011f\u0131daki durumlarda de\u011ferlendirilebilir:<\/p>\n
\u2022 Kas invaziv mesane kanseri (MIBC)<\/p>\n
\u2022 BCG-Unresponsive y\u00fcksek riskli NMIBC<\/p>\n
\u2022 Se\u00e7ilmi\u015f \u00e7ok y\u00fcksek riskli T1 y\u00fcksek dereceli t\u00fcm\u00f6rler<\/p>\n
\u2022 Baz\u0131 agresif histolojik varyantlar<\/p>\n
Her hastan\u0131n tedavi plan\u0131 bireysel olarak olu\u015fturulur.<\/p>\n
MESANEN\u0130N ALINMASI NEDEN GEREKL\u0130 OLAB\u0130L\u0130R?<\/b><\/p>\n
Baz\u0131 mesane kanserlerinde yaln\u0131zca t\u00fcm\u00f6r\u00fcn \u00e7\u0131kar\u0131lmas\u0131 yeterli olmayabilir.<\/p>\n
Kanser mesane kas\u0131na ilerledi\u011finde veya ilerleme riski \u00e7ok y\u00fcksek oldu\u011funda, mesanenin tamamen \u00e7\u0131kar\u0131lmas\u0131 uzun d\u00f6nem kanser kontrol\u00fc a\u00e7\u0131s\u0131ndan en uygun se\u00e7enek olabilir.<\/p>\n
AMEL\u0130YAT NELER\u0130 \u0130\u00c7ER\u0130R?<\/b><\/p>\n
Radikal sistektomi s\u0131ras\u0131nda:<\/p>\n
\u2022 Mesane \u00e7\u0131kar\u0131l\u0131r.<\/p>\n
\u2022 Pelvik lenf nodu diseksiyonu yap\u0131l\u0131r.<\/p>\n
\u2022 Hastaya uygun idrar diversiyonu olu\u015fturulur.<\/p>\n
Ama\u00e7 yaln\u0131zca t\u00fcm\u00f6r\u00fc \u00e7\u0131karmak de\u011fil, kanserin yay\u0131lma riskini de azaltmakt\u0131r.<\/p>\n
MESANE ALINDIKTAN SONRA \u0130DRAR NASIL YAPILIR?<\/b><\/p>\n
Mesane \u00e7\u0131kar\u0131ld\u0131ktan sonra idrar\u0131n v\u00fccuttan uzakla\u015ft\u0131r\u0131lmas\u0131 i\u00e7in yeni bir sistem olu\u015fturulur.<\/p>\n
Ba\u015fl\u0131ca se\u00e7enekler:<\/p>\n
\u2022 \u0130leal konduit<\/p>\n
\u2022 Ortotopik neobladder<\/p>\n
\u2022 Kontinan kutan\u00f6z rezervuar<\/p>\n
En uygun y\u00f6ntem hastan\u0131n sa\u011fl\u0131k durumu, b\u00f6brek fonksiyonlar\u0131 ve ya\u015fam beklentileri dikkate al\u0131narak belirlenir.<\/p>\n
ROBOT\u0130K CERRAH\u0130 M\u00dcMK\u00dcN M\u00dcD\u00dcR?<\/b><\/p>\n
Evet.<\/p>\n
Uygun hastalarda radikal sistektomi robotik cerrahi ile ger\u00e7ekle\u015ftirilebilir.<\/p>\n
Robotik yakla\u015f\u0131m\u0131n uygunlu\u011fu hastan\u0131n klinik \u00f6zelliklerine ve cerrah\u0131n deneyimine g\u00f6re de\u011ferlendirilmelidir.<\/p>\n
EAU 2026\u2019NIN HASTA \u0130\u00c7\u0130N \u00d6NEML\u0130 MESAJI<\/b><\/p>\n
EAU 2026 K\u0131lavuzlar\u0131na g\u00f6re uygun hastalarda radikal sistektominin gereksiz yere geciktirilmesi hastal\u0131\u011f\u0131n ilerleme riskini art\u0131rabilir.<\/p>\n
Bu nedenle:<\/p>\n
\u2022 Cerrahi karar\u0131 do\u011fru zamanda verilmelidir.<\/p>\n
\u2022 Tedavi deneyimli \u00fcroonkoloji merkezlerinde planlanmal\u0131d\u0131r.<\/p>\n
\u2022 Cerrahi \u00f6ncesinde t\u00fcm idrar diversiyonu se\u00e7enekleri ayr\u0131nt\u0131l\u0131 olarak konu\u015fulmal\u0131d\u0131r.<\/p>\n
DO\u00c7. DR. SERDAR YAL\u00c7IN \u0130LE RAD\u0130KAL S\u0130STEKTOM\u0130<\/b><\/p>\n
Do\u00e7. Dr. Serdar Yal\u00e7\u0131n, Bodrum\u2019da radikal sistektomi ve robotik mesane kanseri cerrahisini g\u00fcncel Avrupa \u00dcroloji Birli\u011fi (EAU) k\u0131lavuzlar\u0131 do\u011frultusunda planlamaktad\u0131r.<\/p>\n
Her hasta multidisipliner olarak de\u011ferlendirilir. Cerrahi yakla\u015f\u0131m, lenf nodu diseksiyonu, idrar diversiyonu ve ameliyat sonras\u0131 ya\u015fam kalitesi birlikte ele al\u0131narak ki\u015fiye \u00f6zel tedavi plan\u0131 olu\u015fturulur.<\/p>\n
Bodrum ve Mu\u011fla\u2019n\u0131n yan\u0131 s\u0131ra T\u00fcrkiye\u2019nin bir\u00e7ok ilinden ve yurt d\u0131\u015f\u0131ndan gelen hastalar ikinci g\u00f6r\u00fc\u015f, robotik cerrahi de\u011ferlendirmesi ve ileri \u00fcroonkolojik tedaviler i\u00e7in klini\u011fimize ba\u015fvurmaktad\u0131r.<\/p>\n
Hastalar\u0131m\u0131z\u0131n geri bildirimlerinde en s\u0131k \u00f6ne \u00e7\u0131kan konular; ayr\u0131nt\u0131l\u0131 bilgilendirme, bilimsel yakla\u015f\u0131m, ki\u015fiye \u00f6zel tedavi planlamas\u0131 ve tedavi s\u00fcrecinin her a\u015famas\u0131nda yak\u0131n ileti\u015fimdir.<\/p>\n
SONU\u00c7<\/b><\/p>\n
Radikal sistektomi, uygun hastalarda mesane kanserinin en etkili tedavi se\u00e7eneklerinden biridir. Do\u011fru zamanda uygulanan cerrahi, uygun idrar diversiyonu ve deneyimli cerrahi ekip ile uzun d\u00f6nem ba\u015far\u0131l\u0131 onkolojik sonu\u00e7lar elde edilebilir.<\/p>\n
SIK SORULAN SORULAR<\/b><\/p>\n
Mesanem tamamen al\u0131nacak m\u0131?<\/p>\n
Bu karar t\u00fcm\u00f6r\u00fcn evresine, derecesine ve tedaviye verdi\u011fi yan\u0131ta g\u00f6re verilir.<\/p>\n
Robotik ameliyat herkese uygulanabilir mi?<\/p>\n
Hay\u0131r. Robotik cerrahi her hasta i\u00e7in uygun olmayabilir ve bireysel de\u011ferlendirme gerektirir.<\/p>\n
Mesane al\u0131nd\u0131ktan sonra normal ya\u015fam m\u00fcmk\u00fcn m\u00fcd\u00fcr?<\/p>\n
Bir\u00e7ok hasta uygun rehabilitasyon ve do\u011fru idrar diversiyonu ile g\u00fcnl\u00fck ya\u015fam\u0131na ve sosyal aktivitelerine d\u00f6nebilmektedir.<\/p>\n
KAYNAKLAR<\/b><\/p>\n European Association of Urology (EAU). EAU Guidelines on Muscle-Invasive and Metastatic Bladder Cancer 2026. European Association of Urology (EAU). EAU Guidelines on Non-Muscle-Invasive Bladder Cancer 2026. Witjes JA, Bruins HM, Cathomas R, et al. European Association of Urology (EAU) Guidelines on Muscle-Invasive and Metastatic Bladder Cancer 2026 Update.<\/p>\n<\/li>\n Babjuk M, Burger M, Comp\u00e9rat EM, et al. European Association of Urology (EAU) Guidelines on Non-Muscle-Invasive Bladder Cancer 2026 Update.<\/p>\n<\/li>\n<\/ol>\n B\u0130L\u0130MSEL DAYANAK<\/b><\/p>\n Bu yaz\u0131, European Association of Urology (EAU) 2026 Mesane Kanseri K\u0131lavuzlar\u0131 temel al\u0131narak haz\u0131rlanm\u0131\u015ft\u0131r. \u0130\u00e7erik; g\u00fcncel, kan\u0131ta dayal\u0131 t\u0131bbi bilgilerin hasta dostu ve anla\u015f\u0131l\u0131r bir dille sunulmas\u0131n\u0131 ama\u00e7lamaktad\u0131r. Tan\u0131 ve tedavi plan\u0131, t\u00fcm\u00f6r\u00fcn evresi, patoloji sonu\u00e7lar\u0131, hastan\u0131n genel sa\u011fl\u0131k durumu ve bireysel beklentileri dikkate al\u0131narak deneyimli bir \u00fcroonkoloji ekibi taraf\u0131ndan ki\u015fiye \u00f6zel planlanmal\u0131d\u0131r.<\/p>\n","protected":false},"excerpt":{"rendered":" Radikal sistektomi ne zaman gerekir? Do\u00e7. Dr. Serdar Yal\u00e7\u0131n, endikasyonlar ve karar kriterlerini a\u00e7\u0131kl\u0131yor; do\u011fru zamanda tedaviyi se\u00e7in.<\/p>\n","protected":false},"author":1,"featured_media":23387,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[17],"tags":[101,108,125,104,126],"class_list":["post-23386","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cinsel-saglik","tag-101","tag-hasta","tag-radikal-sistektomi","tag-tedavi","tag-uygun"],"_links":{"self":[{"href":"https:\/\/urohaber.com\/index.php\/wp-json\/wp\/v2\/posts\/23386","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/urohaber.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/urohaber.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/urohaber.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/urohaber.com\/index.php\/wp-json\/wp\/v2\/comments?post=23386"}],"version-history":[{"count":1,"href":"https:\/\/urohaber.com\/index.php\/wp-json\/wp\/v2\/posts\/23386\/revisions"}],"predecessor-version":[{"id":23388,"href":"https:\/\/urohaber.com\/index.php\/wp-json\/wp\/v2\/posts\/23386\/revisions\/23388"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/urohaber.com\/index.php\/wp-json\/wp\/v2\/media\/23387"}],"wp:attachment":[{"href":"https:\/\/urohaber.com\/index.php\/wp-json\/wp\/v2\/media?parent=23386"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/urohaber.com\/index.php\/wp-json\/wp\/v2\/categories?post=23386"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/urohaber.com\/index.php\/wp-json\/wp\/v2\/tags?post=23386"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}\n
https:\/\/uroweb.org\/guidelines\/muscle-invasive-and-metastatic-bladder-cancer<\/p>\n<\/li>\n
https:\/\/uroweb.org\/guidelines\/non-muscle-invasive-bladder-cancer<\/p>\n<\/li>\n